Related Experiment Video
Updated: Jan 23, 2026
09:24
Decellularization and Recellularization of Whole Livers
Published on: February 4, 2011
22.5K
Advances in Hepatic Tissue Bioengineering with Decellularized Liver Bioscaffold
Erik Aranha Rossi1,2,3, Luiz Fernando Quintanilha1,4, Carolina Kymie Vasques Nonaka2
1Escola de Ciências da Saúde-Universidade Salvador-UNIFACS, Salvador, BA, Brazil.
Stem Cells International
|June 15, 2019
Summary
Bioengineered liver scaffolds offer a promising solution to the donor organ shortage for liver transplantation. While significant advances have been made, challenges in cell selection and standardization remain for clinical use.
Area of Science:
- Regenerative Medicine
- Biomaterials Engineering
- Hepatology
Background:
- End-stage liver disease necessitates liver transplantation, but donor organ scarcity limits treatment options.
- Bioengineering using decellularized liver scaffolds presents a novel therapeutic strategy to address organ shortages.
Purpose of the Study:
- To systematically review advances in bioengineering with decellularized liver scaffolds.
- To identify obstacles and challenges hindering clinical application of this technology.
Main Methods:
- Systematic literature review of studies on decellularized liver scaffolds.
- Analysis of technique optimization, including decellularization protocols, quality control, and recellularization.
Main Results:
- Significant progress has been achieved, evolving from animal models to human liver scaffolds.
- Key aspects like scaffold acellularity, matrix composition, and growth factor preservation were highlighted.
- Recellularization techniques and functional tissue restoration show promise.
Conclusions:
- Decellularized liver scaffolds represent a feasible and advancing technology for liver regeneration.
- Standardization of cell types, administration routes, seeding protocols, and scalability is crucial for clinical translation.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
188
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
188
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
02:22Overview of Advanced Functional Groups
29.3K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.3K